Alibaba Health Information Technology Limited (00241.HK) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	50.6B	34.3B	30.6B	27.0B	26.8B
Cost of Revenue	38.5B	26.0B	23.2B	21.1B	21.1B
Gross Profit	12.1B	8.2B	7.4B	5.9B	5.7B
Operating Expenses
R&D Expense	1.2B	788.3M	720.1M	705.4M	677.8M
SG&A Expense	8.4B	2.8B	2.6B	2.1B	2.1B
General & Admin Expense	597.9M	373.4M	390.6M	360.0M	379.5M
Selling & Marketing Expense	4.4B	2.5B	2.3B	1.8B	1.8B
Other Expenses	—	2.8B	2.5B	2.3B	2.8B
Total Operating Expenses	9.6B	6.4B	5.9B	5.2B	5.7B
Cost and Expenses	48.1B	32.4B	29.0B	26.3B	26.7B
Operating Income (EBIT)	2.5B	1.8B	1.6B	717.4M	(31.8M)
Non-Operating
Interest Income	701.9M	447.1M	464.8M	478.0M	331.6M
Interest Expense	1.4M	1.4M	2.6M	6.0M	5.8M
Net Interest Income	700.5M	445.8M	462.2M	472.1M	325.8M
Other Non-Op Income/Expense	483.8M	438.0M	(16.1M)	222.0M	582.8M
Non-Operating Income (excl Interest)	434.7M	422.7M	13.5M	(228.0M)	19.7M
EBT (Pre-Tax Income)	3.0B	2.3B	1.6B	939.4M	551.0M
Income Tax Expense	413.8M	337.9M	128.0M	56.3M	14.5M
Bottom Line
Net Income	2.6B	1.9B	1.4B	883.5M	535.7M
Earnings from Cont. Ops	2.6B	1.9B	1.4B	883.1M	536.5M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	2.6B	1.9B	1.4B	883.5M	535.7M
Per Share
Basic EPS	HK$0.16	HK$0.12	HK$0.09	HK$0.06	HK$0.04
Diluted EPS	HK$0.16	HK$0.12	HK$0.09	HK$0.06	HK$0.04
Revenue Per Share	HK$3.12	HK$2.11	HK$1.90	HK$1.92	HK$1.98
Shares
Basic Shares Outstanding	16.2B	16.2B	16.1B	14.1B	13.5B
Diluted Shares Outstanding	16.2B	16.2B	16.1B	14.1B	13.5B
Profitability Metrics
EBITDA	2.1B	1.4B	1.6B	999.0M	(24.5M)
D&A	49.7M	30.8M	57.6M	53.7M	27.0M
EBIT	2.1B	1.4B	1.6B	945.4M	(51.5M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026